Canada Home Healthcare Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Canada Home Healthcare Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Apr 2022
  • Country Level
  • 350 Pages
  • No of Tables: 83
  • No of Figures: 24

Canada Home Healthcare Market, By Type (Devices, Services and Software), Disease (Heart Diseases, Hypertension, Diabetes, Chronic Obstructive Pulmonary Diseases, Obesity, Dementia/Alzheimer's Diseases, Depression, Asthma, Infective Diseases (HIV/AIDS), Parkinson's Diseases, Bone and Joint Diseases, Smoking and Others) Industry Trends and Forecast to 2029.

Canada Home Healthcare Market Analysis and Insights

Home care services help people with frailty or with acute, chronic, palliative, or rehabilitative healthcare needs to independently live in their community and co-ordinate and manage admission to facility care when living in the community is not a viable alternative. Home care services include nursing, personal support/homemaker, therapy (including physiotherapy, occupational therapy, speech-language pathology, social work, nutrition/dietetics), medical supplies and equipment, and case management.

Canada Home Healthcare Market

Due to rising economic growth, people are more interested in long-term health and wellness. Diabetes patients need devices to monitor their sugar level, check pregnancy, increase the demand of pregnancy strips, and monitor blood pressure resulting in increased demand for devices such as blood glucose monitors, sphygmomanometers, and others. Home healthcare management service helps manage chronic diseases such as diabetes, heart failure or chronic obstructive pulmonary disease (COPD), and cancer. Its service includes nursing service, hospice service, and medication dispensing. Lack of skilled home care service providers and coordination between service providers and patients leads to irregular treatment may create challenges for the Canada home healthcare market. There are recent developments related to the Canada home healthcare market.

The home healthcare market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that the home healthcare market will grow at a CAGR of 8.1% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Type (Devices, Services and Software), Disease (Heart Diseases, Hypertension, Diabetes, Chronic Obstructive Pulmonary Diseases, Obesity, Dementia/Alzheimer's Diseases, Depression, Asthma, Infective Diseases (HIV/AIDS), Parkinson's Diseases, Bone and Joint Diseases, Smoking and Others)

Countries Covered

Canada

Market Players Covered

Medtronic, Koninklijke Philips N.V., ResMed, Abbott, F. Hoffmann-La Roche Ltd, EXTENDICARE, Bayshore HealthCare, Fresenius Medical Care AG & Co. KGaA, 3M, General Electric Company, Saint Elizabeth Healthcare, Omron Healthcare, Inc. (A Subsidiary of OMRON Corporation), AlayaCare, Siemens Healthcare GmbH, Boston Scientific Corporation, Cardinal Health, Fisher & Paykel Healthcare Limited, Coloplast Canada (A Subsidiary of Coloplast Group), Invacare Corporation, Air Liquide Medical Systems (A subsidiary of Air Liquide)

Canada Home Healthcare Market Dynamics

Drivers

  • Increasing Cases of Chronic Diseases Leading to Rising Usage of Home Healthcare Devices

With the rising economic growth, people are more interested in long-term health and wellness. Diabetes patients need devices to monitor their sugar level, check pregnancy, increase the demand of pregnancy strips, and monitor blood pressure, growing demand for devices such as blood glucose monitors, sphygmomanometers, and others. Home healthcare management service helps manage chronic diseases such as diabetes, heart failure or chronic obstructive pulmonary disease (COPD), and cancer. Its service includes nursing service, hospice service, and medication dispensing.

  • Increasing Geriatric Population

As the geriatric population is more prone to chronic disease and injuries, the prevalence rate of their diseases and injuries in Canada leads to demand for home healthcare services to monitor and care for their health. Therefore, the geriatric population and their rising disease rates play a major role in driving the home healthcare market. A glucose meter is used to monitor sugar levels in the blood for insulin administration; insulin injections and or a pen are available. Also, the favourable reimbursement policies in these countries is expected to drive the growth of market.

Furthermore, Increase in strategic initiatives by key players, advancement in medical technology, recent advancements in home healthcare devices, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the home healthcare market.

Canada Home Healthcare Market

Opportunities

  • Increasing Demand for Telehealth

Telehealth uses the electronic gadget to monitor health daily routine activities. Tele-monitoring helps avoid the trip to the hospital by identifying early warning signs like unforeseen blood pressure. Including that it helps monitor blood pressure, heart rate, blood glucose level, oxygen levels, and weight and health status.

Also, the increasing drug approvals will provide beneficial opportunities for the home healthcare market in the forecast period of 2022-2029. Also, the partnership and agreement by major players will escalate the growth rate of the home healthcare market in the future.

Restraints/Challenges

However, the home healthcare workers working in different environments face several safety and health hazards. These hazards include blood-borne pathogens and biological hazards, latex sensitivity, ergonomic hazards from patient lifting, violence, hostile animals, and unhygienic and dangerous conditions. Different hazards threaten patient safety, including violent or unstable patients, unsafe neighbourhoods, potentially dangerous pets, and family members. Patients also have concerns related to the environment, including overheated room temperatures, poor indoor air quality, and unsanitary conditions due to rodents and insects. The cross-contamination transfer of pathogens through direct and indirect contact with animals, raw food, and contaminated inanimate objects can place the frail elderly and others at risk.

This home healthcare market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on home healthcare market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Home Healthcare Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Isolation and non-contact of medical service providers and patients will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in service adherence during the pandemic.

Recent Development

  • In November 2021, AlayaCare acquired Delta Health Technologies, a specialized home health solutions provider. The acquisition of Delta Health Technologies extends AlayaCare’s position as a leading provider of software-as-a-service (SaaS) technology in the home health market. This is a major development in AlayaCare’s commitment to make in-home care a more connected and integrated part of the healthcare continuum.

Canada Home Healthcare Market Scope

Canada home healthcare market is categorized into three notable segments, which are based on type, diseases and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Type

  • Devices
  • Services
  • Software

Based on type, the market is segmented into devices, software, and services. Based on devices, the market is segmented into testing, screening, and monitoring products, therapeutics, mobility care, continence care, and wound care. On the basis of testing, screening, and monitoring products, the market is segmented into blood pressure monitors, blood glucose monitors, cholesterol monitoring devices, pulse oximeters, peak flow meters, heart rate monitors, fetal monitoring devices, HIV test kits, sleep apnea monitors, coagulation monitors, ovulation and pregnancy test kits, Holter and event monitors, colon cancer test kits, home hemoglobin A1C test kits, drug, and alcohol test kits, ECG/EKG devices, temperature monitors, hearing aids and pedometers. Based on therapeutics, the market is segmented into oxygen delivery systems, nebulizers, ventilators, dialysis equipment, insulin delivery devices, inhalers and other therapeutic products. On the basis of mobility care the market is segmented into canes, crutches, mobility scooters, walkers and rollators and wheelchairs. On the basis of continence care the market is segmented into briefs & diapers, urinary catheters, underpads and liners and others. On the basis of wound care the market is segmented into traditional wound dressing, advanced wound dressing, negative pressure wound therapy and others. On the basis of services, the market is segmented into rehabilitation, infusion therapy service, unskilled care, pregnancy care, skilled nursing, hospice and palliative care, technological (virtual / remote / telehealth), companion care, infusion therapy services, medical social working services, durable medical equipment services, post-acute care services, primary care services, urgent care service and others. On the basis of rehabilitation, the market is segmented into occupational therapy, physical therapy and speech & language pathologists. On the basis of unskilled care, the market is segmented into domestic, personal, and others. On the basis of skilled nursing the market is segmented into wound care, diabetic care, cardiac & respiratory assessment, pain management, IV therapy, cancer care and others. On the basis of others, the market is segmented into nutritional, visually impaired. On the basis of software, the market is segmented into agency software, clinical management systems and hospice solutions.

Disease

  • Heart Diseases
  • Hypertension
  • Bone and Joint Diseases
  • Diabetes
  • Chronic Obstructive Pulmonary Diseases
  • Obesity
  • Dementia/Alzheimer's Diseases
  • Infective Diseases (HIV/AIDS)
  • Parkinson's Diseases
  • Smoking
  • Asthma
  • Depression
  • Others

Based on disease, the market is segmented into heart diseases, hypertension, diabetes, chronic obstructive pulmonary diseases, obesity, dementia/Alzheimer’s diseases, depression, asthma, infective diseases (HIV/AIDS), Parkinson’s diseases, bone and joint diseases, smoking and others.

Distribution Channel

  • Direct Tender
  • Retail Sales

Canada Home Healthcare Market

Based on distribution channel, the Canada home healthcare market is segmented into retail sales and direct tender

Canada Home Healthcare Market Regional Analysis/Insights

The interventional cardiology and peripheral vascular devices market is analysed and market size insights and trends are provided by province, type, diseases, and distribution channel as referenced above.

The provinces covered in the market report are Ontario, Quebec, British Colombia, Alberta, and Rest of Canada.

Ontario dominates the Canada home healthcare market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.

Competitive Landscape and Home Healthcare Share Analysis

Canada home healthcare market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on inherited retinal diseases market.

Some of the major players operating in the Canada home healthcare market are Medtronic, Koninklijke Philips N.V., ResMed, Abbott, F. Hoffmann-La Roche Ltd, EXTENDICARE, Bayshore HealthCare, Fresenius Medical Care AG & Co. KGaA, 3M, General Electric Company, Saint Elizabeth Healthcare, Omron Healthcare, Inc. (A Subsidiary of OMRON Corporation), AlayaCare, Siemens Healthcare GmbH, Boston Scientific Corporation, Cardinal Health, Fisher & Paykel Healthcare Limited, Coloplast Canada (A Subsidiary of Coloplast Group), Invacare Corporation, Air Liquide Medical Systems (A subsidiary of Air Liquide), among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global Vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF CANADA HOME HEALTHCARE MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 CANADA HOME HEALTHCARE MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 COUNTRY SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TYPE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL'S MODEL

4.2 PORTER'S FIVE FORCES MODEL

4.3 CANADA UNSKILLED CARE

4.3.1 OVERVIEW

4.3.2 DOMESTIC

4.3.3 PERSONAL

5 EPIDEMIOLOGY

6 CANADA HOME HEALTHCARE MARKET: REGULATIONS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING CASES OF CHRONIC DISEASES LEADING TO RISING USAGE OF HOME HEALTHCARE DEVICES

7.1.2 TECHNOLOGICAL ADVANCEMENT

7.1.3 INCREASING GERIATRIC POPULATION

7.1.4 INSURANCE COVERAGE

7.2 RESTRAINTS

7.2.1 SAFETY CONCERNS

7.2.2 UNMET HOMECARE NEEDS

7.3 OPPORTUNITIES

7.3.1 EMERGING MARKETS

7.3.2 INCREASING DEMAND FOR TELEHEALTH

7.4 CHALLENGES

7.4.1 LACK OF SKILLED HOME CARE SERVICE PROVIDERS

7.4.2 LACK OF COORDINATION BETWEEN SERVICE PROVIDERS AND PATIENTS LEADS TO IRREGULARITY IN TREATMENT

8 CANADA HOME HEALTHCARE MARKET, BY TYPE

8.1 OVERVIEW

8.2 DEVICES

8.2.1 TESTING, SCREENING, & MONITORING PRODUCTS

8.2.1.1 BLOOD PRESSURE MONITORS

8.2.1.2 BLOOD GLUCOSE MONITORS

8.2.1.3 SLEEP APNEA MONITORS

8.2.1.4 PULSE OXIMETERS

8.2.1.5 HEART RATE MONITORS

8.2.1.6 HEARING AIDS

8.2.1.7 HOLTER AND EVENT MONITORS

8.2.1.8 TEMPERATURE MONITORS

8.2.1.9 ECG/EKG DEVICES

8.2.1.10 OVULATION AND PREGNANCY TEST KITS

8.2.1.11 COAGULATION MONITORS

8.2.1.12 CHOLESTEROL MONITORING DEVICES

8.2.1.13 PEAK FLOW METERS

8.2.1.14 PEDOMETERS

8.2.1.15 HIV TEST KITS

8.2.1.16 COLON CANCER TEST KITS

8.2.1.17 HOME HEMOGLOBIN A1C TEST KITS

8.2.1.18 DRUG AND ALCOHOL TEST KITS

8.2.1.19 FETAL MONITORING DEVICES

8.2.2 THERAPEUTIC PRODUCTS

8.2.2.1 INSULIN DELIVERY DEVICES

8.2.2.2 DIALYSIS EQUIPMENT

8.2.2.3 INHALERS

8.2.2.4 NEBULIZERS

8.2.2.5 OXYGEN DELIVERY SYSTEMS

8.2.2.6 VENTILATORS

8.2.2.7 IV EQUIPMENT

8.2.2.8 OTHERS

8.2.3 WOUND CARE

8.2.3.1 ADVANCED WOUND DRESSING

8.2.3.2 TRADITIONAL WOUND DRESSING

8.2.3.3 NEGATIVE PRESSURE WOUND THERAPY

8.2.3.4 OTHERS

8.2.4 MOBILITY CARE

8.2.4.1 CANES

8.2.4.2 CRUTCHES

8.2.4.3 WALKERS & ROLLATORS

8.2.4.4 WHEELCHAIRS

8.2.4.5 MOBILITY SCOOTERS

8.2.5 CONTINENCE CARE

8.2.5.1 BRIEFS & DIAPERS

8.2.5.2 UNDERPADS AND LINERS

8.2.5.3 URINARY CATHETERS

8.2.5.4 OTHERS

8.3 SERVICES

8.3.1 SKILLED NURSING CARE

8.3.1.1 CANCER CARE

8.3.1.2 CARDIAC AND RESPIRATORY ASSESSMENT

8.3.1.3 WOUND CARE

8.3.1.4 DIABETIC CARE

8.3.1.5 PAIN MANAGEMENT

8.3.1.6 IV THERAPY

8.3.1.7 OTHERS

8.3.2 REHABILITATION

8.3.2.1 OCCUPATIONAL THERAPY

8.3.2.2 PHYSICAL THERAPY

8.3.2.3 SPEECH AND LANGUAGE PATHOLOGISTS

8.3.3 UNSKILLED CARE

8.3.3.1 DOMESTIC

8.3.3.2 PERSONAL

8.3.4 HOSPICE & PALLIATIVE CARE

8.3.5 TECHNOLOGICAL (VIRTUAL/REMOTE/TELEHEALTH)

8.3.6 INFUSION THERAPY SERVICES

8.3.7 POST-ACUTE CARE SERVICES

8.3.8 PRIMARY CARE SERVICES

8.3.9 RESPIRATORY THERAPY

8.3.10 PREGNANCY CARE

8.3.11 COMPANION CARE

8.3.12 URGENT CARE SERVICES

8.3.13 MEDICAL SOCIAL WORKING SERVICES

8.3.14 DURABLE MEDICAL EQUIPMENT SERVICES

8.3.15 OTHERS

8.3.15.1 NUTRITIONAL

8.3.15.2 VISUAL IMPAIRED

8.4 SOFTWARE

8.4.1 CLINICAL MANAGEMENT SYSTEMS

8.4.2 AGENCY SOFTWARE

8.4.3 HOSPICE SOLUTIONS

9 CANADA HOME HEALTHCARE MARKET, BY DISEASE

9.1 OVERVIEW

9.2 HEART DISEASES

9.2.1 CONGESTIVE HEART FAILURE (CHF)

9.2.2 CHRONIC ISCHEMIC HEART DISEASE (CHD)

9.2.3 CORONARY ARTERY DISEASE

9.2.4 OTHER DISEASES

9.3 HYPERTENSION

9.4 DEMENTIA/ALZHEIMER'S DISEASES

9.5 DIABETES

9.6 PARKINSON'S DISEASES

9.7 DEPRESSION

9.8 OBESITY

9.9 CHRONIC OBSTRUCTIVE PULMONARY DISEASES

9.1 ASTHMA

9.11 INFECTIVE DISEASES (HIV/AIDS)

9.12 BONE AND JOINT DISEASES

9.13 SMOKING

9.14 OTHERS

10 CANADA HOME HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 RETAIL SALES

11 CANADA HOME HEALTHCARE MARKET, BY PROVINCE

11.1 OVERVIEW

11.2 ONTARIO

11.3 QUEBEC

11.4 BRITISH COLOMBIA

11.5 ALBERTA

11.6 REST OF CANADA

12 CANADA HOME HEALTHCARE MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: CANADA

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 MEDTRONIC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.1.4.1 APPROVALS

14.1.4.2 COLLABORATION

14.2 KONINKLIJKE PHILIPS N.V.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENTS

14.2.4.1 ACQUISITION

14.2.4.2 PRODUCT LAUNCH

14.3 RESMED

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENT

14.3.4.1 ACQUSITION

14.3.4.2 PRODUCT LAUNCHES

14.4 ABBOTT

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.4.4.1 PRODUCT LAUNCHES

14.4.4.2 AGREEMENTS

14.5 F. HOFFMANN-LA ROCHE LTD.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.5.4.1 PRODUCT LAUNCHES

14.6 EXTENDICARE

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 SERVICE PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.6.4.1 AGREEMENT

14.7 BAYSHORE HEALTHCARE

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.7.3.1 LAUNCH

14.7.3.2 CONTRACT

14.7.3.3 ACQUISITION

14.8 FRESENIUS MEDICAL CARE AG & CO. KGAA

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 3M

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

14.1 AIR LIQUIDE MEDICAL SYSTEMS (A SUBSIDIARY OF AIR LIQUIDE)

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 GENERAL ELECTRIC COMPANY

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENTS

14.11.4.1 ACQUISITION

14.12 INVACARE CORPORATION

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENTS

14.12.4.1 LAUNCH

14.13 SAINT ELIZABETH HEALTH CARE

14.13.1 COMPANY SNAPSHOT

14.13.2 SERVICE PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.13.3.1 AWARD

14.13.3.2 ACQUISITION

14.14 SIEMENS HEALTHCARE GMBH

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 ALAYACARE

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.15.3.1 AGREEMENTS

14.16 OMRON HEALTHCARE, INC. (A SUBSIDIARY OF OMRON CORPORATION)

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENTS

14.16.4.1 AGREEMENTS

14.17 BOSTON SCIENTIFIC CORPORATION

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 CARDINAL HEALTH

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.18.4.1 PARTNERSHIP

14.19 COLOPLAST CANADA (A SUBSIDIARY OF COLOPLAST GROUP)

14.19.1 COMPANY SNAPSHOT

14.19.2 REVENUE ANALYSIS

14.19.3 PRODUCT PORTFOLIO

14.19.4 RECENT DEVELOPMENT

14.2 FISHER & PAYKEL HEALTHCARE LIMITED

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENT

14.20.4.1 PRODUCT LAUNCH

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 CANADA HEALTHACARE (2018-2009)

TABLE 2 CANADA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 CANADA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 4 CANADA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 CANADA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 CANADA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 CANADA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 CANADA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 CANADA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 CANADA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 CANADA REHABILIATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 CANADA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 CANADA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 CANADA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 CANADA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 16 CANADA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 17 CANADA HOME HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 18 CANADA HOME HEALTHCARE MARKET, BY PROVINCE, 2020-2029 (USD MILLION)

TABLE 19 ONTARIO HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 ONTARIO DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 ONTARIO TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 ONTARIO THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 ONTARIO WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 ONTARIO MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 ONTARIO CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 26 ONTARIO SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 ONTARIO SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 ONTARIO REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 ONTARIO UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 ONTARIO OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 ONTARIO SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 ONTARIO HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 33 ONTARIO HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 34 ONTARIO HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 35 QUEBEC HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 36 QUEBEC DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 37 QUEBEC TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 38 QUEBEC THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 39 QUEBEC WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 40 QUEBEC MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 QUEBEC CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 42 QUEBEC SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 43 QUEBEC SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 QUEBEC REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 QUEBEC UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 QUEBEC OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 QUEBEC SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 48 QUEBEC HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 49 QUEBEC HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 50 QUEBEC HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 BRITISH COLOMBIA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 52 BRITISH COLOMBIA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 53 BRITISH COLOMBIA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 BRITISH COLOMBIA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 BRITISH COLOMBIA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 BRITISH COLOMBIA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 BRITISH COLOMBIA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 BRITISH COLOMBIA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 BRITISH COLOMBIA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 BRITISH COLOMBIA REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 BRITISH COLOMBIA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 BRITISH COLOMBIA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 63 BRITISH COLOMBIA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 64 BRITISH COLOMBIA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 65 BRITISH COLOMBIA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 66 BRITISH COLOMBIA HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 67 ALBERTA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 68 ALBERTA DEVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 ALBERTA TESTING, SCREENING, & MONITORING PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 ALBERTA THERAPEUTIC PRODUCTS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 71 ALBERTA WOUND CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 ALBERTA MOBILITY CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 73 ALBERTA CONTINENCE CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 ALBERTA SERVICES IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 ALBERTA SKILLED NURSING CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 ALBERTA REHABILITATION IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 ALBERTA UNSKILLED CARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 ALBERTA OTHERS IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 ALBERTA SOFTWARE IN HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 ALBERTA HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 81 ALBERTA HEART DISEASES IN HOME HEALTHCARE MARKET, BY DISEASE, 2020-2029 (USD MILLION)

TABLE 82 ALBERTA HOME HEALTHCARE MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 83 REST OF CANADA HOME HEALTHCARE MARKET, BY TYPE, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 CANADA HOME HEALTHCARE MARKET: SEGMENTATION

FIGURE 2 CANADA HOME HEALTHCARE MARKET: DATA TRIANGULATION

FIGURE 3 CANADA HOME HEALTHCARE MARKET: DROC ANALYSIS

FIGURE 4 CANADA HOME HEALTHCARE MARKET: REGIONAL VS COUNTRY ANALYSIS

FIGURE 5 CANADA HOME HEALTHCARE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 CANADA HOME HEALTHCARE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 CANADA HOME HEALTHCARE MARKET: DBMR POSITION GRID

FIGURE 8 CANADA HOME HEALTHCARE MARKET: SEGMENTATION

FIGURE 9 TECHNOLOGICAL ADVANCEMENT AND INCREASING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE CANADA HOME HEALTHCARE MARKET FROM 2022 TO 2029

FIGURE 10 DEVICES SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE CANADA HOME HEALTHCARE MARKET FROM 2022 & 2029

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL HOME HEALTHCARE MARKET

FIGURE 12 CANADA HOME HEALTHCARE MARKET: BY TYPE, 2021

FIGURE 13 CANADA HOME HEALTHCARE MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 14 CANADA HOME HEALTHCARE MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 15 CANADA HOME HEALTHCARE MARKET: BY TYPE, LIFELINE CURVE

FIGURE 16 CANADA HOME HEALTHCARE MARKET: BY DISEASE, 2021

FIGURE 17 CANADA HOME HEALTHCARE MARKET: BY DISEASE, 2022-2029 (USD MILLION)

FIGURE 18 CANADA HOME HEALTHCARE MARKET: BY DISEASE, CAGR (2022-2029)

FIGURE 19 CANADA HOME HEALTHCARE MARKET: BY DISEASE, LIFELINE CURVE

FIGURE 20 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 21 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 22 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 23 CANADA HOME HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 24 CANADA HOME HEALTHCARE MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Ontario is the dominating region in the Canada Home Healthcare Market.
The Canada Home Healthcare Market growth rate is 8.1% during the forecast period.
Increasing Cases of Chronic Diseases Leading to Rising Usage of Home Healthcare Devices & Increasing Geriatric Population are the growth drivers of the Canada Home Healthcare Market.
The type, diseases and distribution channel are the factors on which the Canada Home Healthcare Market research is based.
Major companies in the Canada Home Healthcare Market are Medtronic, Koninklijke Philips N.V., ResMed, Abbott, F. Hoffmann-La Roche Ltd, EXTENDICARE, Bayshore HealthCare, Fresenius Medical Care AG & Co. KGaA, 3M, General Electric Company, Saint Elizabeth Healthcare, Omron Healthcare, Inc. (A Subsidiary of OMRON Corporation), AlayaCare, Siemens Healthcare GmbH, Boston Scientific Corporation, Cardinal Health, Fisher & Paykel Healthcare Limited, Coloplast Canada (A Subsidiary of Coloplast Group), Invacare Corporation, Air Liquide Medical Systems (A subsidiary of Air Liquide).